Abstract
The in vivo body distribution and the pharmacokinetics of a 20mer double-stranded nuclear factor κB decoy oligodeoxynucleotide (ODN) complexed with 25-kDa poly(ethylene imine) (PEI), low molecular weight 2.7-kDa PEI, and PEGylated PEI [bPEI(25k)-glPEG(550)50] after intravenous injection were studied in BALB/c mice using a double-labeling technique to follow simultaneously the distribution of both complex components. The polymers were radioactively labeled with 125I by Bolton-Hunter reagent and the decoys with [γ-32P]ATP by an enzymatic 5′-end-labeling technique. After i.v. bolus injections into the jugular vein, organ samples were taken after 15 min, 2 h and 12 h. For pharmacokinetic studies blood and plasma samples were collected from 20 s up to 2 h. Uncomplexed decoy was found to be degraded already after 15 min and was rapidly eliminated renally into urine. Complexation with the homopolymers increased the organ levels and circulation time of ODN after 15 min, with similar organ distribution profiles for 125I and 32P. In contrast to the behavior of free ODN, the complexes were mainly distributed into liver and spleen. Whereas the organ concentrations of 125I remained high over 12 h, the 32P values of ODN decreased in a time-dependent manner, likely due to separation of the complexes and degradation of the DNA. Although PEGylated PEI demonstrated a slower 125I-uptake into the RES organs compared with 25-kDa PEI due to the shielding effect of PEG [poly(ethylene glycol)], it was not able to better stabilize the complexes in the circulation or protect DNA from degradation.
Footnotes
-
This work was supported by grants from the Dr. August and Dr. Anni Lesmüller Foundation, Munich, Germany (D.F.), the National Multiple Sclerosis Society, the American Heart Association, and the National Institutes of Health (U.B.). B.O. received stipends from the Daimler-Benz Foundation, the Foerderverein for Neurology Marburg, and the Prof. Adolf Schmidtmann Foundation Marburg, Germany.
-
ABBREVIATIONS: PEI, poly(ethylene imine); AUC, area under the curve; LMW, low molecular weight; NF-κB nuclear factor κB; ODN, oligodeoxynucleotide; PEG, poly(ethylene glycol); T4 PNK, T4 polynucleotide kinase; TCA, trichloroacetic acid; PEI(PEG)50, bPEI(25k)-g-lPEG(550)50; N/P ratio, total nitrogen of the polymer per DNA phosphate ratio; %ID, percentage of injected dose; ANOVA, analysis of variance; RES, reticuloendothelial system.
- Received February 4, 2004.
- Accepted June 11, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|